Nautilus Biotechnology elects Class I directors, ratifies PwC, reduces board size to 7

Nautilus Biotechnology, Inc.

Sujal Patel re-elected with 84.3M votes for; Matthew McIlwain elected with 82.2M votes for.
PricewaterhouseCoopers LLP ratified as auditor for 2025 with 99.5M votes for.
Board reduced from 9 to 7 directors effective after annual meeting.
Directors Vijay Pande and Michael Altman did not stand for re-election; McIlwain resigned as Class II to stand for Class I.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.